These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance. Greeson NM, Mixon W, Allan WC. Int J Pharm Compd; 2020; 24(5):371-379. PubMed ID: 32886634 [Abstract] [Full Text] [Related]
3. Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration. Greeson NMH, Mixon W, Allan WC. Int J Pharm Compd; 2020; 24(4):270-276. PubMed ID: 32649298 [Abstract] [Full Text] [Related]
5. Analytic Methods Used in Quality Control in a Compounding Pharmacy. Allen LV. Int J Pharm Compd; 2017; 21(1):31-37. PubMed ID: 28346196 [Abstract] [Full Text] [Related]
7. Choosing a Vial Processing Line for Aseptic Compounding: Part 1. Noorian S, Vahedi N. Int J Pharm Compd; 2016; 20(4):283-292. PubMed ID: 28333673 [Abstract] [Full Text] [Related]
8. Performance Improvement in 503A Compounding Pharmacies: A PLAN FOR ASSESSMENT, IMPLEMENTATION, AND SUSTAINED SUCCESS. Pritchett J, Mixon W, O'Connell K. Int J Pharm Compd; 2016; 20(1):29-36. PubMed ID: 27125054 [Abstract] [Full Text] [Related]
11. How gaps in regulation of compounding pharmacy set the stage for a multistate fungal meningitis outbreak. Teshome BF, Reveles KR, Lee GC, Ryan L, Frei CR. J Am Pharm Assoc (2003); 2014; 54(4):441-5. PubMed ID: 25063265 [Abstract] [Full Text] [Related]
12. Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies. Pritchett J, McCrory G, Kraemer C, Jensen B, Allen LV. Int J Pharm Compd; 2018; 22(1):7-16. PubMed ID: 29385381 [Abstract] [Full Text] [Related]
15. [Relation of pharmaceutical to commercial drug preparations]. Nord Med; 1953 Aug 27; 50(35):1202-3. PubMed ID: 13087833 [No Abstract] [Full Text] [Related]
17. Improving and enforcing compounding pharmacy practices to protect patients. Pegues DA. Clin Infect Dis; 2006 Oct 01; 43(7):838-40. PubMed ID: 16941363 [No Abstract] [Full Text] [Related]
18. Leveraging a multidisciplinary oversight committee to ensure USP <797> and <800> compliance at a Veterans Affairs health system. Wrzesniewski CE, Park HK. Am J Health Syst Pharm; 2022 Feb 08; 79(4):276-282. PubMed ID: 34724546 [Abstract] [Full Text] [Related]
19. Pharmacy compounding of high-risk level products and patient safety. Mullarkey T. Am J Health Syst Pharm; 2009 Sep 01; 66(17 Suppl 5):S4-13. PubMed ID: 19710449 [Abstract] [Full Text] [Related]
20. [Relation of pharmaceutical to commercial drug preparations in Denmark]. Nord Med; 1953 Aug 27; 50(35):1203-4. PubMed ID: 13087834 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]